MUCOPOLYSACCHARIDOSIS TYPE II
Article is devoted to one of the orphan diseases — mucopolysaccharidosis (MPS), which is the result of any lysosomal enzyme deficiency (which determines the type of illness). The most common is the MPS type II (Hunter syndrome), developing as a result of deficiency of the enzyme alpha-L-iduronosulph...
Saved in:
| Main Authors: | N.D. Vashakmadze, L.S. Namazova-Baranova, A.K. Gevorkyan, L.M. Kuzenkova, A.D. Khristochevskiy, L.M. Vysotskaya, A.S. Dadashev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2011-06-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NPD TYPE C — WAY TO THE EFFECTIVE THERAPY THROUGH TIMELY DIAGNOSIS
by: L.S. Namazova-Baranova, et al.
Published: (2011-12-01) -
Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01) -
Neuronopathic Types of Mucopolysaccharidoses: Pathogenesis and Emerging Treatments
by: L. A. Osipova, et al.
Published: (2015-11-01) -
Idursulfase Beta (Hunterase) Therapeutic Experience in a Patient with Mucopolysaccharidosis Type II
by: Nato D. Vashakmadze, et al.
Published: (2023-08-01) -
Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II
by: Julia G. Levina, et al.
Published: (2022-07-01)